NCT05942612

A Phase I Study of SHR -2001 in Healthy Subjects

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2001 After a Single or Multiple Subcutaneous Injections in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 72 (actual)
• Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This study is a phase 1 single dose or multiple doses escalation study of SHR-2001 in healthy subjects. The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-2001 in healthy subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	SHR-2001	Subcutaneous injection, single dose or multiple doses.
DRUG	Placebo	Subcutaneous injection, single dose or multiple doses.

Timeline

• Start date: 2023-07-19
• Primary completion: 2024-11-20
• Completion: 2024-11-20
• First posted: 2023-07-12
• Last updated: 2025-06-25

Locations

1 site across 1 country: China